Alector (ALEC) Interest Expenses (2019 - 2026)
Alector (ALEC) posted quarterly Interest Expenses of $201000.0 for Q1 2026, down 6.07% year-over-year from $214000.0 in Q1 2025, and down 68.45% quarter-over-quarter from $637000.0 in Q4 2025.
Alector (ALEC) Interest Expenses (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported Interest Expenses for 8 consecutive years, with $201000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses fell 6.07% year-over-year to $201000.0; the TTM figure through Mar 2026 stood at $9.8 million (up 9.4% YoY), while the FY2025 annual figure was $30.5 million, up 210.68% from the prior year.
- Interest Expenses eased to $201000.0 in Q1 2026 per ALEC's latest filing, from $637000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $204.5 million in Q4 2023 and bottomed at $8000.0 in Q2 2025.
- Historically, Interest Expenses has averaged $25.6 million across 5 years, with a median of $207500.0 in 2025.
- Annual changes were most pronounced in 2022 — Interest Expenses jumped 17196.42% — and 2023, when it slumped 98.15%.
- Alector's Interest Expenses stood at $164.3 million in 2022, then increased by 24.49% to $204.5 million in 2023, then slumped by 95.75% to $8.7 million in 2024, then plunged by 92.68% to $637000.0 in 2025, then slumped by 68.45% to $201000.0 in 2026.
- Business Quant data shows ALEC's Interest Expenses at $201000.0 in Q1 2026, $637000.0 in Q4 2025, and $24000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 97,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 97,000.00 |
| Jun 30, 2026 | 97,000.00 |
| Mar 31, 2026 | 201,000.00 |
| Mar 31, 2026 | 201,000.00 |
| Dec 31, 2025 | 637,000.00 |
| Dec 31, 2025 | 637,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 214,000.00 |
| Mar 31, 2025 | 214,000.00 |
| Dec 31, 2024 | 8.70 Mn |
| Dec 31, 2024 | 8.70 Mn |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Mar 31, 2024 | 183,000.00 |